References
- Sharma S. Streptococcus Group A Infections. eMedicine.com ( last updated November 9, 2004).
- Hausman MR, Lisser SP. Hand infections. Orthop Clin North Am 1992; 23: 171–85
- Sharkawy A, Low DE, Saginur R, Gregson D, Schwartz B, Jessamine P, Green K, McGeer A; Ontario Group A streptococcal Study Group. Severe group A streptococcal soft-tissue infections in Ontario: 1992–1996. Clin Infect Dis 2002;34:454–60.
- Critchley IA, Sahm DF, Thornsberry C, Blosser-Middleton RS, Jones ME, Karlowsky JA. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999. Diagn Microbiol Infect Dis 2002; 42: 129–35
- Brown DM, Young VL. Hand infections. South Med J 1993; 86: 56–66
- Efstratiou A, Emery M, Lamagni TL, Tanna A, Warner M, George RC. Increasing incidence of group A streptococcal infections amongst injecting drug users in England and Wales. J Med Microbiol 2003; 52: 525–6
- DiNubile MJ, Lipsky BA. Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother 2004;53 (suppl 2):ii37–50.
- Yuen JC, Feng Z. Salvage of limb and function in necrotising fasciitis of the hand: role of hyperbaric oxygen treatment and free muscle flap coverage. South Med J 2002; 95: 255–7
- Patel RR, Younai S, Narayanan K, Wahba H, Stofman GM. Necrotizing streptococcal fasciitis of the hand: case report. Clin Infect Dis 1996; 22: 586–7
- Tsai E, Failla JM. Hand infections in the trauma patient. Hand Clin 1999; 15: 373–86
- Stevens DL, Bryant AE, Hackett SP. Antibiotic effects on bacterial viability, toxin production and host response. Clin Infect Dis 1995; 20(suppl 2)S154–7
- Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis 1999; 18: 1096–100